AVLN
Avalyn Pharma Inc. Common Stock
There isn't enough reported data to score AVLN yet.
AVLN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate AVLN's fundamentals.
AVLN PE Valuation
AVLN has no meaningful PE right now: it lost money over the past year.
AVLN Forward outlook
There aren't enough analyst estimates for AVLN to show an outlook.
AVLN Earnings Per Share
AVLN Quarterly Revenue
AVLN Free Cash Flow
AVLN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +50% | +14.7M shares |
AVLN Net Leverage
AVLN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AVLN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 34.7 | Neutral |
AVLN's weekly RSI is 44 (neutral) and its Stochastic is 35 (neutral).
AVLN PE vs Healthcare Sector
AVLN has no meaningful PE right now: it lost money over the past year.
AVLN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.1 | 13% above |
| 20 week MA | $30.4 | 0.5% above |
AVLN is in an uptrend: it's above all two of its weekly moving averages, and 0.5% above its 20-week average.
AVLN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $29.8 | $30.6 | +2.5% |
It's up 2.5% so far in 2026.